Key result
Insulin resistance and hyperinsulinemia in PCOS may increase cardiovascular risk.
Why the study?
The role of insulin resistance and hyperinsulinemia in the pathogenesis of polycystic ovary syndrome and its contribution to cardiovascular risk remain unclear.
This review highlights the potential link between insulin resistance in PCOS and increased cardiovascular risk, calling for large prospective studies to confirm this association.
No takes yet. Share an insight, caveat, or question.
May support closer CV monitoring in PCOS; leaves open whether insulin resistance independently drives risk or warrants intervention.
Paolo Moghetti (2002) conducted a review in Polycystic ovary syndrome (PCOS). Insulin resistance was evaluated. Insulin resistance and associated hyperinsulinemia are common features of polycystic ovary syndrome that may increase cardiovascular risk, though large prospective studies are needed for definitive proof.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: